Skip to main content
Home

Search


NEI on Social Media | Search A-Z | en español | Text size S M L
  • About NEI
    • NEI Research Accomplishments
    • Budget and Congress
    • About the NEI Director
    • History of the NEI
    • NEI 50th Anniversary
    • NEI Women Scientists Advisory Committee (WSAC)
    • Board of Scientific Counselors
    • National Advisory Eye Council (NAEC)
    • Donating to the NEI

    Menu About NEI Block

     Contact Us

     Visiting the NIH Campus

    Mission Statement

    As part of the federal government’s National Institutes of Health (NIH), the National Eye Institute’s mission is to “conduct and support research, training, health information dissemination, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems and requirements of the blind.”

  • News & Events
    • Events Calendar
    • NEI Press Releases
    • News from NEI Grantees
    • Spokesperson bios
    • Statistics and Data
    • Resources for the media

    Pressroom Contacts

    Dustin Hays - Chief, Science Communication
    dustin.hays@nih.gov

    Kathryn DeMott, Media Relations
    Kathryn.DeMott@nih.gov

    NEI Office of Communications
    (301)496-5248

  • Health Information
    • Frequently asked questions
    • Clinical Studies
    • Spanish Language Information
    • Publications Catalog
    • Photos and Images
  • Grants and Funding
    • Extramural Research
    • Division of Extramural Science Programs
    • Division of Extramural Activities

    Extramural Contacts

    National Eye Institute
    Division of Extramural Research
    6700B Rockledge Dr., MSC 6914
    Bethesda, MD 20892
    (FedEx, UPS, and other courier services use: Bethesda MD 20817)
    301-451-2020

  • Research at NEI
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Laboratories, Sections and Units
    • eyeGENE
    • Division of Epidemiology and Clinical Applications

    Office of the Scientific Director

    Sheldon S. Miller, Ph.D., Scientific Director
    David M. Schneeweis, Ph.D., Deputy Scientific Director

    Office of the Clinical Director

    Brian P. Brooks, M.D, Ph.D., Clinical Director
    Emily Y. Chew, M.D., Deputy Clinical Director

  • Education Programs
    • National Eye Health Education Program (NEHEP)
    • Diabetic Eye Disease Education Program
    • Glaucoma Education Program
    • Low Vision Education Program
    • Hispanic/Latino Program
    • Vision and Aging Program
    • African American Program
  • Training and Jobs
    • Jobs
    • NEI Summer Intern Program
    • Diversity In Vision Research & Ophthalmology (DIVRO)
    • Student Training Programs

    To search for current job openings visit HHS USAJobs

Home » NEI Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation
Listen

NEI Audacious Goals Initiative (AGI)

  • AGI Home
  • News
  • AGI Projects
  • AGI Events and Reports
  • About the Initiative
  • About the Goal
  • Funding Opportunities
AGI mail

AGI updates

The latest on NEI’s Audacious Goals Initiative.

NEI Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation

The submission deadline has passed.

The winners have been selected:

Dennis Clegg, University of California, Santa Barbara, Calif.
Regenerative Therapy for Retinal Disease
To treat degenerative retinal disease with an off-the-shelf tissue graft that could be implanted in the back of the eye to replace cells lost to disease.

Robert Duvoisin, Oregon Health and Science University,
Portland, Ore.
Restoration of Vision by Opto-electronic Stimulation
To restore vision by making nerve cells in the eye sensitive to light so that images captured by a camera can be converted to nerve signals that are sent to the brain.

Yingbin Fu, University of Utah, Salt Lake City, Utah
Precise Gene Editing In Vivo
To permanently correct any disease-associated mutations in a patient through the use of molecules that are specially designed to target mutated DNA sequences and that can be delivered safely and efficiently into the eye.

Steven Pittler, University of Alabama, Birmingham, Ala.
Using Molecular Scissors Genome Editing to Cure Ocular Genetic Disease
To permanently correct gene defects in patients at the site of the mutation using molecules that act like scissors to precisely replace genome errors with the correct DNA sequence.

Rajesh Rao, Washington University School of Medicine in
St. Louis and The Retina Institute, St. Louis, Mo.
An Audacious Goal: Reprogramming the Retina
To directly reprogram easy-to-isolate skin or blood cells to retinal cells using gene therapy and other techniques to enable repair strategies for degenerative retinal diseases.

Tonia Rex, Vanderbilt University, Nashville, Tenn.
Functional and Structural Neuroregeneration
To restore functional vision in patients who experience loss of axons-the threadlike extensions of a nerve cell that conduct electrical impulses-from the optic nerve as a result of traumatic optic neuropathy or glaucoma by complete axon regeneration.

Julia Richards, University of Michigan, Ann Arbor, Mich.
Fountains of Youth for the Eye
To turn back the aging process in the eye so that ocular diseases like age-related macular degeneration or glaucoma start 10, 20, or 30 years later than they now do.

Jeffrey Stern, Capital Region Retina, PLLC, Albany, N.Y.
Endogenous Retinal Repair: Releasing our Inner Salamander
To repair the retina by activating stem cells residing within the eye, awakening reparative processes that occur naturally in amphibians and other animals but which lay dormant in human patients.

Russell Van Gelder, University of Washington, Seattle, Wash.
Reversing Retinal Blindness Using Small Molecules
To restore vision to patients with retinal diseases through the use of a photoswitch, a small molecule that is chemically modified to become active or inactive after exposure to certain wavelengths of light.

Janey Wiggs, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
Vision BioBank - A Network of Ocular Phenotyping Centers Using Genomic and Epidemiologic Data to Promote Personalized Ophthalmology
To create a network of biobanks that collect corresponding phenotype (physical characteristics) and genotype (genetic) data of people with certain eye diseases; the biobanks could be used for a wide range of studies, including the development of sensitive and specific gene tests that could accurately determine a person’s risk for glaucoma, age-related macular degeneration, diabetic retinopathy, and other common complex blinding diseases as well as their likely response to certain therapies.

The judges for the competition were:

Christopher Austin, MD (National Center for Advancing Translational Sciences, NIH)
Robert Balaban, PhD (National Heart, Lung, and Blood Institute, NIH)
Brian Brooks, MD, PhD (National Eye Institute, NIH)
Emily Chew, MD (National Eye Institute, NIH)
Mary Frances Cotch, PhD (National Eye Institute, NIH)
Bruce Cumming, PhD (National Eye Institute, NIH)
Donald Gagliano, MD (Department of Defense)
William Gahl, MD, PhD (National Human Genome Research Institute, NIH)
Michael Gottesman, MD (National Cancer Institute and Office of the Director, NIH)
Story Landis, PhD (National Institute of Neurological Disorders and Stroke, NIH)
Robert Nussenblatt, MD (National Eye Institute, NIH)
Anand Swaroop, PhD (National Eye Institute, NIH)
M. Roy Wilson, MD (National Institute on Minority Health and Health Disparities, NIH)

For more information, please visit the NEI Audacious Goals Development Meeting.

Last Reviewed: 
February 2013
  • NEI Home
  • Contact Us
  • A-Z Site Map
  • NEI on Social Media
  • Information in Spanish (Información en español)
  • Website, Social Media Policies and Other Important Links
  • NEI Employee Emergency Information
  • NEI Intranet (Employees Only)
  • Department of Health and Human Services
  • The National Institutes of Health
  • USA.gov

*PDF files require the free Adobe® Reader® software for viewing.

Technical questions about this website can be addressed to the NEI Website Manager.